Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Understanding the Immunological Pathways in Psoriasis
Simona Roxana Georgescu, Mircea Tampa, Constantin Căruntu, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 739-739
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Neutrophils in Psoriasis
Chih-Chao Chiang, Wei-Jen Cheng, Michal Korinek, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 212
Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin
Yanyun Jiang, Lam C. Tsoi, Allison C. Billi, et al.
JCI Insight (2020) Vol. 5, Iss. 20
Open Access | Times Cited: 211
Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation
Fengli Xu, Jixiang Xu, Xia Xiong, et al.
Redox Report (2019) Vol. 24, Iss. 1, pp. 70-74
Open Access | Times Cited: 174
Current Developments in the Immunology of Psoriasis.
Franziska Grän, Andreas Kerstan, Edgar Serfling, et al.
The Yale Journal of Biology and Medicine (2020) Vol. 93, Iss. 1, pp. 97-110
Closed Access | Times Cited: 173
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 127
Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases
Qi Jiang, Guocan Yang, Fan Xiao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 105
Current Concepts of Psoriasis Immunopathogenesis
Marijana Vičić, Marija Kaštelan, Ines Brajac, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11574-11574
Open Access | Times Cited: 105
Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics
Robert G. Petit, Amanda Cano, A. Ortiz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4983-4983
Open Access | Times Cited: 84
Molecular and Cellular Mechanisms of Itch in Psoriasis
Eriko Komiya, Mitsutoshi Tominaga, Yayoi Kamata, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8406-8406
Open Access | Times Cited: 75
Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets
Lisha Li, Jiaye Lu, Jun Liu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 15
Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins
Antonia Cianciulli, Rosa Calvello, Chiara Porro, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 505-505
Open Access | Times Cited: 9
Gasdermin E-mediated keratinocyte pyroptosis participates in the pathogenesis of psoriasis by promoting skin inflammation
Yingfei Li, Yi He, Fangyuan Yang, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 3, pp. 385-396
Open Access | Times Cited: 9
Measuring fatigue: a meta‐review
Myrela O. Machado, Na‐Young Cindy Kang, Felicia Tai, et al.
International Journal of Dermatology (2020) Vol. 60, Iss. 9, pp. 1053-1069
Open Access | Times Cited: 64
Homocysteine and psoriasis
Xiran Lin, Xianmin Meng, Zhiqi Song
Bioscience Reports (2019) Vol. 39, Iss. 11
Open Access | Times Cited: 61
Topical delivery of fluocinolone acetonide integrated NLCs and salicylic acid enriched gel: A potential and synergistic approach in the management of psoriasis
Madhulika Pradhan, Krishna Yadav, Deependra Singh, et al.
Journal of Drug Delivery Science and Technology (2020) Vol. 61, pp. 102282-102282
Closed Access | Times Cited: 53
Psoriasis: What Is New in Markers of Disease Severity?
Mircea Tampa, Mădălina Irina Mitran, Cristina Iulia Mitran, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 337-337
Open Access | Times Cited: 6
Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances
Dominik Samotij, Bogusław Nedoszytko, Joanna Bartosińska, et al.
Advances in Dermatology and Allergology (2020) Vol. 37, Iss. 2, pp. 135-153
Open Access | Times Cited: 47
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities
Amit Srivastava, Tara Chand Yadav, Harvinder Kour Khera, et al.
Journal of Autoimmunity (2021) Vol. 118, pp. 102614-102614
Closed Access | Times Cited: 39
Transdermal Delivery of Indirubin-Loaded Microemulsion Gel: Preparation, Characterization and Anti-Psoriatic Activity
Enxue He, Hailing Li, Xiaokun Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3798-3798
Open Access | Times Cited: 23
Oral administration of punicalagin attenuates imiquimod‐induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF‐κB signaling pathways
Yuqian Wang, Dan Han, Yingjian Huang, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 713-726
Closed Access | Times Cited: 14
IL-23/Th17 Axis: A Potential Therapeutic Target of Psoriasis
Vineet Kumar, Amit Sharma, Deepak Kumar Upadhyay, et al.
Current Drug Research Reviews (2021) Vol. 14, Iss. 1, pp. 24-36
Closed Access | Times Cited: 29
Perspective insights of small molecules, phytoconstituents and biologics in the management of psoriasis: A focus on targeting major inflammatory cytokine pathways
Husna Kadagothy, Shweta Nene, Etikala Amulya, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175668-175668
Closed Access | Times Cited: 11
Innovative Approaches to Psoriasis: Small Molecules Targeting Key Signaling Pathways
Meeral Gosia, Gaurav Doshi, Siddhi Bagwe Parab, et al.
Immunological Investigations (2025), pp. 1-37
Closed Access
Comparing adalimumab biosimilars in the clinical practice of psoriatic patients
Domenico Giordano, Antonio Di Guardo, Annamaria Larosa, et al.
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
Association between the exposure to brominated flame retardants and psoriasis risk among U.S. adults: A population-based study
Jingbo Zhang, Xiangyun Shi, Genlong Bai, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 291, pp. 117836-117836
Open Access
Page 1 - Next Page

Scroll to top